Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scion Accuses Abbott Of Misappropriating Clo-Sur Wound Dressing Secrets

This article was originally published in The Gray Sheet

Executive Summary

Scion Cardio-Vascular, Inc. is accusing Abbott Laboratories of lifting elements of its Clo-Sur P.A.D. marketing campaign, among other infractions, in a six-count complaint filed Nov. 22 in Miami federal court

You may also be interested in...

Scion v. Abbott

Scion Cardio-Vascular drops suit accusing Abbott of misappropriating Clo-Sur P.A.D. wound dressing trade secrets. The firm says it will conserve resources for marketing efforts (1"The Gray Sheet" Dec. 9, 2002, p. 18)...

Bristol/Exelixis Detail Survival Benefit For Opdivo/Cabometyx In Renal Cancer

Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts